StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Status:
Withdrawn
Trial end date:
2020-11-24
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects of a silicone topical wound dressing (StrataXRT)
and to see how well it works in preventing radiation dermatitis (skin burns and side effects
caused by radiation) in pediatric patients undergoing radiation therapy. StrataXRT may help
prevent or decrease severe skin rash, pain, itching, skin peeling, and dry skin in pediatric
patients undergoing radiation therapy to the brain or spinal cord.